Tech Enhanced Investing

Piccadily Agro Industries witnessed a positive movement in its share price on the BSE, with the stock trading at RS 576.60, registering a gain of 0.21% compared to its previous close of RS 575.40.

The stock commenced trading at RS 573.50 and moved within an intraday range of RS 573.50 to RS 582.80. Around 8,052 shares had changed hands on the counter during the session.

The company’s shares, carrying a face value of RS 10, have recorded a 52-week peak of RS 805.00 on September 22, 2025, while the 52-week low stands at RS 515.00, touched on March 30, 2026. Over the last week, the stock traded between RS 565.00 and RS 637.00. Piccadily Agro currently commands a market capitalization of approximately RS 5,675.29 crore.

In terms of shareholding structure, promoters hold a dominant 68.57% stake in the company, while institutional investors own 1.53% and non-institutional investors account for 29.91%.

The company has expanded its premium whisky portfolio with the introduction of Indri Ilika, a new expression under its acclaimed Indri Single Malt Indian Whisky label. Produced at the Indri Distillery near the Himalayan foothills, the whisky is matured in a distinctive blend of ex-Spanish Sherry and ex-American Bourbon oak casks, creating a rich and sophisticated flavor profile.

Targeted at international travelers and whisky connoisseurs, Indri Ilika offers notes of tropical fruits, subtle smokiness, and layered complexity. The limited-edition release will be available exclusively through selected global travel retail outlets and is expected to be priced at around $80.

Piccadily Agro Industries operates across the distillery and sugar segments and has built a strong premium spirits portfolio featuring Indri single malt whiskies, blended malt offerings, and Camikara aged rum made from sugarcane juice. The latest launch further strengthens the company’s presence in the premium global spirits market.

Shares of Monarch Surveyors and Engineering Consultants witnessed strong buying interest on the BSE, rising 4.33% to Rs 226.50, an increase of Rs 9.40 from the previous close of Rs 217.10.

The stock opened at Rs 217.10 and moved within a day's range of Rs 217.10 to Rs 227.00. Around 7,800 shares changed hands during the trading session.

Over the past 52 weeks, the company's stock has recorded a high of Rs 435.00 on July 29, 2025, and a low of Rs 165.00 on March 30, 2026. During the last week, the share traded between Rs 201.00 and Rs 245.75. The company currently commands a market capitalization of approximately Rs 321.20 crore.

Shareholding data shows promoters holding a dominant 72.35% stake in the company, while institutional investors own 6.32% and non-institutional investors hold 21.33%.

In a significant business development, Monarch Surveyors and Engineering Consultants has received a Letter of Acceptance (LoA) from the Maharashtra Maritime Board for preparing a Detailed Project Report (DPR) for the proposed New Marine Shipyard Cluster at Dighi in Raigad district. The assignment also includes geotechnical investigations and topographical surveys, with the contract valued at Rs 2.16 crore.

The new order is expected to strengthen the company's project portfolio and support its future business growth.

Monarch Surveyors and Engineering Consultants provides end-to-end consultancy services for infrastructure projects, covering surveying, design, and technical supervision. Its expertise spans roads, railways, metro systems, town planning, geospatial mapping, land acquisition, water infrastructure, transmission lines, pipelines, and various other civil engineering sectors.

Maruti Suzuki India shares were trading marginally higher during the session, gaining 0.04% to reach RS 13,063.05 compared to the previous close of RS 13,058.10 on the BSE. The stock opened at RS 13,077.00 and moved between an intraday high of RS 13,181.40 and a low of RS 12,914.50. More than 16,900 shares changed hands during the trading session.

The company’s stock, carrying a face value of RS 5, has recorded a 52-week high of RS 17,371.60 and a 52-week low of RS 12,019.75. Over the past week, the share price has fluctuated between RS 13,862.50 and RS 12,723.20. Maruti Suzuki currently commands a market capitalization of approximately RS 4.11 lakh crore.

Shareholding data indicates that promoters own 58.53% of the company, while institutional investors hold 38.29% and non-institutional investors account for 3.19%.

In a significant step toward sustainable mobility, Maruti Suzuki has unveiled India’s first flex-fuel passenger vehicle. The newly introduced technology allows the car to operate on ethanol-petrol blends ranging from E20 to E100, providing customers with greater fuel flexibility. The company has incorporated this technology into the Wagon R, one of its most popular models and a vehicle that has previously led alternative fuel initiatives through CNG and LPG variants.

The launch aligns with the country’s objectives of enhancing energy security and promoting cleaner transportation solutions. The adoption of flex-fuel vehicles is also expected to contribute to reducing dependence on crude oil imports while creating additional demand for ethanol, potentially benefiting India’s agricultural sector and farmers.

Maruti Suzuki India is one of the country’s leading automobile manufacturers, producing passenger cars, utility vehicles, and vans. The company also offers related services including vehicle financing, fleet management solutions, and certified pre-owned car sales.

Tata Technologies witnessed strong buying interest in Tuesday’s trading session, with its stock rising 2.23% on the BSE. The share price climbed by RS 16.70 to trade at RS 765.50 compared to the previous close of RS 748.80.

The stock opened at RS 750.00 and moved within a day’s range of RS 750.00 to RS 772.20. Trading activity remained healthy, with nearly 2.40 lakh shares changing hands during the session.

Over the past 52 weeks, the company’s shares have touched a peak of RS 797.00 on June 10, 2025, while the lowest level recorded was RS 507.50 on March 30, 2026. During the last week, the stock traded between RS 602.00 and RS 772.20. Tata Technologies currently commands a market capitalization of approximately RS 31,054.84 crore.

Promoters continue to hold a majority stake of 55.18% in the company. Institutional investors own 9.08%, while non-institutional investors account for 35.73% of the shareholding.

In a significant development, Tata Technologies has announced the fourth edition of its flagship engineering innovation challenge, InnoVent-27. The initiative has been expanded through strategic collaborations with Emerson’s Test & Measurement business and Amazon Web Services (AWS), providing engineering students across India with an opportunity to develop technology-driven solutions for real-world industrial applications.

This year’s theme, “AI at the Edge,” focuses on leveraging real-time, localized artificial intelligence to solve challenges in the automotive, industrial heavy machinery, and aerospace sectors. Participants will be encouraged to create innovative solutions aimed at improving safety, operational efficiency, sustainability, and autonomous capabilities.

The competition invites ideas across a broad range of applications, including advanced driver assistance systems (ADAS), autonomous technologies, predictive maintenance, intelligent manufacturing, digital twin solutions, smart inspection systems, connected industrial ecosystems, and energy-efficient mobility technologies.

Open to third- and fourth-year engineering students, InnoVent-27 also promotes diversity and inclusion by encouraging participation from teams that include women innovators and differently-abled members.

Tata Technologies is a global engineering and digital services company that provides product development, engineering, and turnkey digital transformation solutions to leading original equipment manufacturers (OEMs) and Tier-1 suppliers worldwide.

Bajaj Housing Finance witnessed positive momentum in trading on Friday, with its shares climbing 1.19% to RS 84.40 on the BSE, gaining 0.99 points from the previous close of RS 83.41.

The stock opened at RS 83.40 and moved between an intraday high of RS 86.39 and a low of RS 83.35. More than 3.21 lakh shares changed hands during the session. The company currently commands a market capitalization of approximately RS 70,316.57 crore.

Over the past year, the stock has touched a 52-week high of RS 128.40 on June 9, 2025, and a 52-week low of RS 72.60 on March 30, 2026. During the last week, it traded within a range of RS 81.85 to RS 89.18.

Shareholding data shows promoters holding a dominant 86.70% stake in the company, while institutional investors own 2.16% and non-institutional investors account for 11.13%.

The company has strengthened its funding base by raising RS 1,991.83 crore through a private placement of 2,00,000 Secured Redeemable Non-Convertible Debentures (NCDs), each carrying a face value of RS 1,00,000. The securities are proposed to be listed on the BSE's Wholesale Debt Market segment. The allotment was approved by the company's Debenture Allotment Committee during its meeting held on June 5, 2026.

Bajaj Housing Finance operates as a non-deposit-taking housing finance company registered with the National Housing Bank. It provides customized financing solutions for the purchase, construction, and renovation of residential as well as commercial properties across India.

Glenmark Pharmaceuticals shares traded marginally higher on the BSE, rising 0.08% to RS 2,183.30 compared to the previous close of RS 2,181.45. The stock opened at RS 2,185.30 and moved between an intraday high of RS 2,215.00 and a low of RS 2,181.00. Around 6,145 shares changed hands during the session.

The company’s stock, carrying a face value of RS 1, has recorded a 52-week high of RS 2,471.05 and a 52-week low of RS 1,515.55. Over the past week, the share price has fluctuated between RS 2,144.40 and RS 2,439.70. Glenmark currently commands a market capitalization of approximately RS 62,329.69 crore.

Shareholding data shows promoters own 46.65% of the company, while institutional investors hold 39.67% and non-institutional investors account for 13.68%.

The positive sentiment follows the launch of Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), by Glenmark’s wholly owned US subsidiary, Glenmark Pharmaceuticals Inc. The newly introduced product is a generic version that is both bioequivalent and therapeutically equivalent to UCB Inc.’s Vimpat Injection.

According to industry sales estimates, the reference drug Vimpat Injection generated annual sales of nearly $15.2 million in the US market during the 12 months ended April 2026, highlighting the commercial opportunity for Glenmark’s generic offering.

Glenmark Pharmaceuticals is a research-driven global pharmaceutical company with a strong presence across generic medicines, specialty products, and over-the-counter healthcare segments, operating in multiple international markets.

Mumbai: Shares of Alembic Pharmaceuticals moved higher in early trade after the company announced that it has secured final approval from the US Food and Drug Administration (USFDA) for its generic Haloperidol Tablets in multiple strengths.

The stock was trading at RS 738.90, registering a gain of RS 3.20, or 0.43%, compared to its previous close of RS 735.70 on the BSE. During the session, the stock opened at RS 736.10 and fluctuated between an intraday high of RS 743.00 and a low of RS 728.20. Around 19,676 shares had changed hands on the counter.

Alembic Pharmaceuticals received final USFDA clearance for its Abbreviated New Drug Application (ANDA) for Haloperidol Tablets USP in strengths of 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg. The approved product is the generic equivalent of Haldol Tablets, originally marketed by Ortho McNeil Pharmaceutical.

Haloperidol is prescribed for the treatment of symptoms associated with psychotic disorders and is also used to manage tics and vocal manifestations linked to Tourette’s Disorder in both children and adults.

According to IQVIA data, the approved product segment recorded an estimated market opportunity of approximately $27 million in the 12-month period ending March 2026. With this latest approval, Alembic’s cumulative USFDA ANDA portfolio has expanded to 240 approvals, comprising 221 final approvals and 19 tentative approvals.

On the market front, the company’s market capitalization stood at about RS 14,524.05 crore. The stock has touched a 52-week high of RS 1,107.80 and a 52-week low of RS 635.30. Promoters hold 69.74% of the company, while institutional and non-institutional investors own 20.43% and 9.83%, respectively.

Alembic Pharmaceuticals operates across India formulations, international generics, and active pharmaceutical ingredients (APIs), supported by its vertically integrated manufacturing capabilities.

Innovision witnessed strong buying interest during trading on Thursday, with its share price rising 8.83% to RS 309.25 on the BSE, compared to the previous closing level of RS 284.15. The stock gained RS 25.10 during the session.

The counter opened at RS 288.20 and moved within a trading range of RS 288.20 to RS 324.35. A total of 58,660 shares changed hands during the trading session.

The stock, which carries a face value of RS 10 and is listed under the BSE 'B' group category, touched its 52-week peak of RS 468.60 on March 23, 2026, while its 52-week low of RS 283.75 was recorded on June 4, 2026. Over the past week, the share has traded between RS 283.75 and RS 332.95.

Innovision currently commands a market capitalization of approximately RS 735.95 crore. Promoters hold a 74.17% stake in the company, while institutional investors and non-institutional investors own 0.45% and 25.38%, respectively.

The positive momentum in the stock follows the company's receipt of a Letter of Award (LoA) from the National Highways Authority of India (NHAI) for a project valued at around RS 26.35 crore. The contract involves operating the Mundiyar Fee Plaza on the Baran-Shivpuri section of New NH-27 in Madhya Pradesh, along with maintenance of nearby toilet facilities and replenishment of consumable items.

The project is scheduled to commence on July 11, 2026, and will remain in force for a period of one year.

Innovision operates across multiple service segments, including manpower solutions, toll plaza operations and management, and skill development training programs for clients throughout India.

Bharat Gears shares traded higher on the BSE, gaining 0.79% to RS 114.30, compared to the previous closing price of RS 113.40. The stock opened at RS 116.20 and touched an intraday high of RS 116.20, while the day's low stood at RS 114.30. Around 120 shares changed hands during the trading session.

The company’s stock, which carries a face value of RS 10, had reached a 52-week high of RS 154.35 on September 29, 2025, and a 52-week low of RS 83.65 on March 30, 2026. Over the past week, the stock has fluctuated between RS 105.30 and RS 121.70. Bharat Gears currently commands a market capitalization of approximately RS 177.50 crore.

Shareholding data indicates that promoters hold a 55.33% stake in the company, while institutional investors own 1.44% and non-institutional investors account for the remaining 43.23%.

In a significant development, Bharat Gears has invested RS 1.27 crore in Hexa Energy HR5 by acquiring 13,134 equity shares with a face value of RS 101 each. The shares were subscribed at an issue price of RS 970 per share, giving Bharat Gears a 29.55% stake in the company’s paid-up equity capital.

The investment has been undertaken to meet regulatory requirements under prevailing electricity laws and to facilitate the procurement of solar power for the company’s manufacturing facilities located in Faridabad and Mumbra.

Bharat Gears is recognized as one of India’s leading gear manufacturers and a prominent player in global gear technology. The company produces a broad portfolio of automotive components, including ring gears, pinions, transmission gears, shafts, differential gears, and gearboxes, catering primarily to the automotive sector.

DMR Engineering witnessed strong buying interest in Tuesday’s trading session, with its stock rising 8.89% to RS 34.30 on the BSE, gaining RS 2.80 from the previous close of RS 31.50.

The stock opened at RS 32.00 and touched an intraday high of RS 34.30, which also remained its day’s low, while around 25,350 shares changed hands during the session.

The company’s share, having a face value of RS 10, recorded a 52-week peak of RS 69.65 on August 29, 2025, and recently hit a 52-week low of RS 28.18 on June 4, 2026. Over the past week, the stock has traded within a range of RS 28.18 to RS 45.99. DMR Engineering currently commands a market capitalization of approximately RS 35.34 crore.

Shareholding data shows promoters own 69.32% of the company, while the remaining 30.68% is held by non-institutional investors.

In a significant business development, DMR Engineering has been awarded a contract by Dorjilung Hydro Power in Bhutan. The assignment involves providing short-term owner’s engineer services for the 1,125 MW Dorjilung Hydropower Project. The nine-month contract is valued at RS 2.58 crore, excluding applicable taxes.

Formerly known as DMR Hydroengineering & Infrastructures, DMR Engineering specializes in engineering and design solutions for infrastructure projects, offering end-to-end services from project conceptualization to commissioning.